Status:
UNKNOWN
Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics
Lead Sponsor:
Zhejiang Cancer Hospital
Conditions:
Gastric Cancer
Signet Ring Cell Carcinoma
Eligibility:
All Genders
Brief Summary
Gastric signet ring cell carcinoma (GSRCC) possesses unique epidemiology and pathogenesis in the field of cancer, but its incidence is low. Unfortunately, there is currently a lack of systematic resea...
Eligibility Criteria
Inclusion
- confirmed GSRCC by pathology, where GSRCC is defined as having a percentage of signet ring cell ≥ 50%
- patients with complete medical information
- patients with survival follow-up information
Exclusion
- patients with other malignant tumors
- presence of other pathological components (e.g., neuroendocrine carcinoma and squamous cell carcinoma, etc)
- incomplete or lost case information
Key Trial Info
Start Date :
March 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05985577
Start Date
March 2 2023
End Date
July 30 2024
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Hangzhou, Zhejiang, China, 310000